Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nurr1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinson's disease

Nurr1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinson's disease

US Patent 10946019 · Granted Mar 16, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant NURR1 gene in Parkinson's disease2006
DNA encoding glutamate gated chloride channels1996